Professionals can capitalize on market opportunities by enhancing their skills in effective investigations and CAPA systems, utilizing data-driven strategies, and applying risk-based approaches to ...
As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...
The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for ...
The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer. This is an ASCO Meeting Abstract from the 2012 Quality Care Symposium. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results